WHO says another cough syrup manufactured in India is contaminated, recommends immediate action
WHO has informed that QP Pharmachem Limited Company of Punjab produces this cough syrup.
Time to Read 2 Min
Another cough syrup manufactured in India has raised questions about its quality. Issuing a medical alert, the World Health Organization (WHO) has termed a cough syrup manufactured in India as contaminated. WHO has said that cough syrup of an Indian company has been found contaminated in the Marshall Islands and Micronesia.
However, in this medical alert, WHO did not say whether there was any loss of life due to the cough syrup made in India. But, WHO believes that along with Guaifenesin Syrup TG Syrup, Diethylene Glycol and Ethylene Glycol have been found in trace amounts. Its use can put the lives of humans at risk. These chemicals were identified by the Australian regulator. On April 6, this information was given to WHO.
However, no response has been received from the Union Health Ministry on this alert of WHO. Sources say that after receiving WHO's email, the Haryana and Punjab governments were recommended to take immediate action in this matter.
Names of Punjab-Haryana company came to the fore
WHO has informed that QP Pharmachem Limited Company of Punjab produces this cough syrup. The company has tied up with a company named Trillium Pharma, which is based in Haryana, for distribution in other countries. No response has been received from both these companies in this matter. WHO has appealed to all member countries not to use this cough syrup. WHO says that both these companies have not provided any guarantee to WHO on the safety and quality of cough syrup.
Questions raised on quality for the third time
This is not the first time that questions have been raised about the quality of India-made medicines, known as the World Pharmacy. Earlier, WHO has issued alerts twice. More than 300 children were said to have died of kidney damage in Gambia, Indonesia and Uzbekistan from the syrup made by various manufacturers in India. However, in the investigation of Indian regulatory organizations, the batches of these medicines were found to be completely safe.